SCHEMBL25460825

SCHEMBL25460825

CNC(=O)C(C)(C)c1cccc(Cl)c1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDK1 Q15118 6/20 0.42
▸ PDK2 Q15119 6/20 0.42
▸ PDK3 Q15120 6/20 0.42
▸ PDK4 Q16654 6/20 0.42
▸ TP53 P04637 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ GCK P35557 1/20 0.36
▸ LMNA P02545 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ NOTUM Q6P988 1/20 0.35
▸ TYK2 P29597 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25460803 0.83 GAA (0.41) PDK1PDK2PDK3PDK4TP53
SCHEMBL1626611 0.81 NOTUM (0.40) PDK1PDK2PDK3PDK4GAA
SCHEMBL1626668 0.81 PLCG1 (0.44) PDK1PDK2PDK3PDK4GAA
SCHEMBL25464178 0.79 EPHX2 (0.43) RAB9AKDM4EALDH1A1KMT2AMEN1
SCHEMBL25460829 0.76 GAA (0.47) PDK1PDK2PDK3PDK4GAA
SCHEMBL1626474 0.74 ALDH1A1 (0.42) MAPTPOLBKDM4EALDH1A1KMT2A
SCHEMBL31619473 0.73 PDK1 (0.41) PDK1PDK2PDK3PDK4GAA
SCHEMBL30148352 0.73 PDK1 (0.39) PDK1PDK2PDK3PDK4GAA
SCHEMBL8225791 0.73 CA2 (0.44) PDK1PDK2PDK3PDK4GAA
SCHEMBL31560752 0.71 LMNA (0.37) PDK1PDK2PDK3PDK4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151074-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR PDK1 1840/4885PDK2 2856/4885PDK3 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback